Hospitality July 11, 2026 · 7 min

The Wegovy effect: how GLP-1 weight-loss drugs are rewriting restaurant menus, portions and margins

Roughly 1 in 9 US adults now takes a GLP-1 drug like Wegovy or Ozempic, and diners on them eat less, drink less, and visit restaurants less often. Here's what the data shows, how chains are responding — and why it's a food-costing problem, not just a menu one.

A few years ago, GLP-1 receptor agonists — semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — were a niche diabetes and obesity treatment. They are now common enough that restaurant chains discuss them on quarterly earnings calls. According to Gallup, 11% of US adults currently take a GLP-1 medication for weight loss, up from just 3% in 2024, and 15% report having used one at some point. J.P. Morgan’s February 2026 analysis projects the US GLP-1 user base growing from roughly 10 million today to 25–30 million by 2030.

That’s no longer a rounding error for anyone selling food for a living. It’s a large, fast-growing group of customers whose appetite, month over month, is shrinking.

What GLP-1s actually do to how people eat

GLP-1 drugs suppress appetite directly — users describe it as reduced “food noise,” less of the constant background craving that drives snacking and second helpings. The clearest data on what that does to real spending comes from a Cornell-led study published in the Journal of Marketing Research (Hristakeva, Liaukonytė and Feler, December 2025), which tracked roughly 150,000 US households’ retail and food-service purchases matched against self-reported GLP-1 use.

The findings: within six months of starting a GLP-1, households cut grocery spending by 5.3% on average — more than 8% among higher-income households — and cut spending at fast-food restaurants and coffee shops by roughly 8%. Almost a third of GLP-1 users said they were visiting restaurants less often; that figure rose to 43% for fast food specifically. The categories that dropped hardest were exactly the ones you’d expect: chocolate, pastries and alcohol. Spending shifted toward fruit and protein-rich foods instead.

The industry is already rewriting its menus

This isn’t theoretical for restaurant chains — it’s already showing up in earnings calls and product launches:

Darden Restaurants (Olive Garden’s parent) added smaller-portion options to the menu, with CEO Rick Cardenas telling investors in December that the change was designed to give guests more choices — including diners who want less food while on a GLP-1. Fortune reported that Olive Garden and The Cheesecake Factory have both been trimming portion sizes.
Chipotle launched a “High Protein Cup” in response to what chief brand officer Chris Brandt described as growing demand for protein-forward, snack-sized, accessible-priced options. CEO Scott Boatwright told analysts on the chain’s Q4 earnings call that the cup addresses “a fast-growing trend with the adoption of GLP-1s” — but also noted the smaller, cheaper item is less profitable per order than a full-size entrée, even as it drives more visits.
Nestlé launched Vital Pursuit, a frozen-food line targeted at GLP-1 users, back in 2024. USA CEO Marty Thompson told CNBC the company now designs products specifically around protein and fiber content for this segment.

Where the pain concentrates: alcohol and buffets

Two segments are absorbing an outsized share of the impact.

Alcohol is the clearest casualty. Diageo’s US tequila sales fell 23% in the first half of fiscal 2026, with Don Julio down 20.9% and Casamigos down 30.9%; the company’s shares hit a 13-year low as North America sales declined 9.4%. Gallup separately found the share of Americans who drink alcohol at all fell from 62% in 2023 to 54% in 2025 — GLP-1 use is only one factor among several (health trends, generational shifts), and not every drinks company agrees it’s the main driver: Constellation Brands’ CEO has publicly called the GLP-1 effect on its business “negligible,” pointing instead to broader economic pressure. The data doesn’t fully settle the argument, but the direction is consistent across the sector.

All-you-can-eat and buffet formats face a structural problem rather than a marketing one. Their economics assume a certain amount of overconsumption to average out against the guests who eat comparatively little. As more diners on GLP-1s take smaller portions, skip the carb-heavy sides, and leave starches and sauces unfinished, that assumption gets shakier — and food waste per cover rises even as total consumption falls.

Here’s the part that’s easy to miss in the marketing narrative: a smaller portion does not automatically mean the same margin percentage. Chipotle said as much directly — its smaller, cheaper protein cup drives more visits but is less profitable per order than the entrée it’s replacing. That’s not surprising once you break down why: labor, rent, service time and packaging per cover don’t shrink in proportion to the plate. If the price drops faster than the true cost per cover does, your food-cost percentage on that item quietly gets worse, not better.

The reformulation side cuts the same way. Swapping a carb-heavy side — rice, pasta, bread — for a higher-protein one to match demand often means swapping a cheap ingredient for a more expensive one at scale. Menu-engineer for GLP-1 diners without re-costing the recipe, and you can end up with a dish that looks lighter and more modern on the plate while quietly costing more per portion than the one it replaced.

Three questions worth asking about any dish you’re adapting for this trend:

If you shrink a portion, do you know the new food-cost percentage — not just the lower price you’re now charging for it?
When you swap a carb-heavy side for a protein-forward one, have you re-costed the recipe, or only updated the plate photo and the menu copy?
Could you tell, dish by dish, which items are quietly losing margin because the portion shrank but the recipe cost per unit didn’t move with it?

How CalcMenu helps you see this before it hits your margin

Adapting the menu to GLP-1 diners is the easy part — every kitchen can shrink a portion or add a protein cup. Knowing what that change actually did to your margin is the part that gets skipped.

Recipe costing in minutes, not days — resize a portion or swap an ingredient and see the new food-cost percentage immediately, instead of finding out at month-end that the “healthier” version costs more than the one it replaced.
Menu-wide visibility — spot the dishes where check average dropped faster than food cost, so a well-intentioned menu update doesn’t silently erode margin across a whole category.
Waste tracking — for buffet and all-you-can-eat operators, see where unfinished portions are adding cost per cover even as total consumption falls.

CalcMenu doesn’t decide your menu strategy for GLP-1 diners. It makes sure that whichever way you adapt it, you know exactly what it costs — before it shows up as a margin surprise.

Want to see what your current portion sizes and recipes are really costing you? Book a free 15-minute call with our team — no commitment: Schedule a call.

Sources

Related sectors

Hospitality

Talk to a human — 20 min

Comments

Comments coming soon.